Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1126 (LINC01126) is a long non-coding RNA (lncRNA) gene located on chromosome 17 (BioGPS and other resources list it as mapped to chromosome 2 or 17; these may reflect differences among genome builds, but chromosome 17 appears in multiple authoritative summaries). LINC01126 is transcribed into a non-protein-coding RNA molecule, and its product does not encode a functional protein. It has been implicated in several cellular functions including the regulation of cell growth, programmed cell death, immune system response, and potentially gene expression at the RNA level. While it has been associated with general lncRNA-regulated processes in cancer biology, its specific functional mechanisms and direct disease links are still under active investigation, and it is not established as a classical therapeutic target such as a receptor, enzyme, transporter, or ion channel.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1126 (LINC01126).